AMY WEBSTER: Open Payments
NPI 1932544582 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 43 payments from 16 companies in 2025. Trend: 2023 $561 · 2024 $826 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $101 |
| Corcept Therapeutics | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| PFIZER INC. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Biogen, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, QULIPTA, Korlym, Kerendia, NURTEC ODT, REXULTI, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
